The UK NSC recommendation on Glaucoma screening in adults
Find general information about population health screening.
Why is screening not recommended by UK NSC?
- there are no tests which can accurately predict who is going to develop the disease
- many people diagnosed with early glaucoma will never suffer visual impairment in their lifetime
- there isn't any good-quality evidence that demonstrates treatment to be better than no treatment. Additionally, the treatments can cause harm
- the effectiveness of a screening programme has not been studied; therefore there is no evidence to suggest that a programme would reduce the burden of the disease to the UK population
More about Glaucoma
Glaucoma is the name given to a group of eye conditions that affect vision. Glaucoma often affects both eyes, usually in varying degrees. One eye may develop glaucoma quicker than the other. If glaucoma is left untreated it can cause blindness. However, if it's diagnosed and treated early enough, further damage to your vision can be prevented.
» Read more about glaucoma on NHS Choices
• Age UK
• Association for Independent Optometrists and Dispensing Opticians
• Association of Optometrists
• British and Irish Orthoptic Society
• British Association of Retinal Screening
• College of Optometrists
• Faculty of Public Health
• International Glaucoma Association
• Royal College of General Practitioners
• Royal College of Ophthalmologists
• Royal National Institute of Blind People (RNIB)
• UK Vision Strategy
The stakeholder groups will be involved when the recommendation is next reviewed.
If you think your organisation should be added, please
More information for stakeholders can be found in appendix C of the UK NSC evidence review process.
More optionsGo to top